Abcl stock forecast.

A $14.3 billion market cap divided by 330 million shares outstanding equals a valuation of $43.33 per share. Discounting a year 2030, $43.33 valuation, using a 10% discount rate gives us a present ...Analyst Forecast. According to 7 analysts, the average rating for ABCL stock is "Strong Buy." The 12-month stock price forecast is $22.33, which is an …ABCL News. 14 days ago - AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 - Business Wire 27 days ago - AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 - Business Wire 4 weeks ago - AbCellera Reports Q3 2023 Business Results - Business Wire 4 …According to our research, ABCL stock is a bad long-term investment. ABCL share price has been in a bear cycle for the past year. AbCellera Biologics Inc. …PLTR Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for Palantir Technologies in the last 3 months. The average price target is $14.67 with a high forecast of $25.00 and a low forecast of $5.00. The average price target represents a -23.59% change from the last price of $19.20.

5 abr 2023 ... Their average price target stands at $19, implying 266% upside potential. AbCellera Biologics (ABCL). Pipette adding fluid to one of several ...

Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. AbCellera Biologics stock news, updates & related news. Find out why AbCellera Biologics's (ABCL) news sentiment is 14.35% more negative in relation to stocks in the Healthcare sector.Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K. Price to Earnings (P/E) -9.8.

Recursion Pharmaceuticals Inc. 6.87. -0.18. -2.55%. Get Abcellera Biologics Inc (ABCL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.ABCL Stock Performance: A Look at May 26, 2023. On May 26, 2023, Abcellera Biologics Inc (ABCL) saw a significant increase in its stock price, with shares trading at $28.00, up 306.39% from the previous day’s closing price. This surge in price can be attributed to the positive outlook of the 9 analysts who offer 12-month price forecasts …Their ACN share price targets range from $279.00 to $410.00. On average, they anticipate the company's stock price to reach $337.26 in the next year. This suggests that the stock has a possible downside of 0.2%. View analysts price targets for ACN or view top-rated stocks among Wall Street analysts.What is AbCellera Biologics Inc. (ABCL) stock EPS forecast? AbCellera Biologics Inc. beat analysts’ expectations during the last earnings period by -28.57%. AbCellera Biologics Inc. reported earnings of -$ 0.10 per share on Nov 2, 2023, while the forecasted EPS was -$ 0.14. Market Closed. ABCL. AbCellera Biologics.ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...

We don't have any Insights for this stock currently. Aditya Birla Cap. Share Price Returns. 1 Day, 1.67%. 1 Month ...

AbCellera's Q2 2023 financials reveal declining revenues and high R&D expenses, leading to caution in investment decision. Learn why I rate ABCL stock a hold.

52-Week Range $3.87 - $14.97. Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Jan 5, 2023 · A $14.3 billion market cap divided by 330 million shares outstanding equals a valuation of $43.33 per share. Discounting a year 2030, $43.33 valuation, using a 10% discount rate gives us a present ... Analyst Future Growth Forecasts. Earnings vs Savings Rate: ABC's forecast earnings growth (7.2% per year) is above the savings rate (2.1%). Earnings vs Market: ABC's earnings (7.2% per year) are forecast to grow slower than the Australian market (9.1% per year). High Growth Earnings: ABC's earnings are forecast to grow, but not …Nov 13, 2023 · High Growth Earnings: ABCL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ABCL's revenue (23.9% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: ABCL's revenue (23.9% per year) is forecast to grow faster than 20% per year.

Nov 29, 2023 · According to 40 analysts, the average rating for MSFT stock is "Strong Buy." The 12-month stock price forecast is $392.0, which is an increase of 3.51% from the latest price. 4 ago 2023 ... As of Friday, August 04, AbCellera Biologics Inc's ABCL share price has dipped by 13.34%, which has investors questioning if this is right ...Business Finance Consider company ABC. Today it is 1st of January 2023 and ABC has just paid a dividend of £3 million. The expected earnings of ABC for the next 30 years are forecast to grow at a rate of 15% per annum. From 1st of January 2053 and onwards the earnings of ABC are expected to grow at a rate of 5%.AbCellera ( NASDAQ: ABCL) listed on the Nasdaq in December 2020, completing a monstrous initial public offering of 24.15m shares at a price of $20 per share, for funds of ~$483m, which would be ...Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Long-term ACB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Our analysts are offering long term price forecasts for Aurora Cannabis Inc. In 2050, the median target price for ACB is $ 38.03, with a high estimate of $ 80.99 and a low estimate of $ 14.32. The median estimate represents a +8166.35% increase from the last price of $ 0.4601.Jun 6, 2022 · Insiders purchased significant amount of AbCellera stock directly after Q1. See why I ABCL shares are increasingly attractive for long-term, patient investors.

Find the latest Standard Lithium Ltd. (SLI) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. According to 10 stock analysts, the average 12-month stock price forecast for NIO Inc. stock is $12.44, which predicts an increase of 73.99%. The lowest target is $8.00 and the highest is $18. On average, analysts rate NIO Inc. stock as a buy. Analyst Consensus: Buy. Target Low Average Median

Mumbai Stock Market & Finance report, prediction for the future: You'll find the Alembic Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Alembic Pharmaceuticals's Alembic Pharmaceuticals Ltd shares and potentially its market environment have been in a bullish cycle in the last 12 months (if …AbCellera Biologics Stock Forecast. Is AbCellera Biologics Stock Undervalued? The current AbCellera Biologics [ ABCL] share price is $4.47. The Score for ABCL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. ABCL is currently trading in the 40-50% percentile range relative to its historical Stock ... See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Nov 29, 2023 · Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -618.82% from its current level, while the stock would need to crash -111.42% from its current level to reach the projected low. Future criteria checks 4/6. Palantir Technologies is forecast to grow earnings and revenue by 34.8% and 18% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 18.4% in 3 years.According to 16 stock analysts, the average 12-month stock price forecast for SOFI stock stock is $8.78, which predicts an increase of 12.13%. The lowest target is $3.00 and the highest is $15. On average, analysts rate SOFI stock stock as a hold. Analyst Consensus: Hold. Target Low Average Median High; Price: $3.00: $8.78: $8.00: …

According to our current BILI stock forecast, the value of Bilibili Inc. shares will drop by -8.68% and reach $ 10.31 per share by December 6, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).BILI stock recorded 13/30 (43%) green days with 6.20% price …

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.54 per share a year ago.

Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ABCL. The Nasdaq Stock Market. Indicate by check mark whether the registrant (1) ... The market price of our common stock could decline if one or more of these ...5 abr 2023 ... Their average price target stands at $19, implying 266% upside potential. AbCellera Biologics (ABCL). Pipette adding fluid to one of several ...What is AbCellera Biologics Inc. (ABCL) stock EPS forecast? AbCellera Biologics Inc. beat analysts’ expectations during the last earnings period by -28.57%. AbCellera Biologics Inc. reported earnings of -$ 0.10 per share on Nov 2, 2023, while the forecasted EPS was -$ 0.14. Market Closed. ABCL. AbCellera Biologics.See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.19 sept 2023 ... ... (ABCL) Stock's Price and Volume. The market has been down on AbCellera Biologics Inc (ABCL) stock recently. ABCL gets a Bearish score from ...805.37p. (31.55% Upside) Based on 13 Wall Street analysts offering 12 month price targets for HSBC Holdings in the last 3 months. The average price target is 805.37p with a high forecast of 1,000.00p and a low forecast of 575.00p. The average price target represents a 31.55% change from the last price of 612.20p. Highest Price Target 1,000.00p.Aditya Birla Sun Life AMC Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 12,911.38 Crore) operating in Financial Services sector. Aditya Birla Sun Life AMC Ltd. key Products/Revenue Segments include Fees & Commission Income for the year ending 31-Mar-2023.For ...According to 40 analysts, the average rating for MSFT stock is "Strong Buy." The 12-month stock price forecast is $392.0, which is an increase of 3.51% from the latest price.ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...

Apple Inc. Common Stock. $191.45 +1.76 +0.93%. Find the latest dividend history for AbCellera Biologics Inc. Common Shares (ABCL) at Nasdaq.com.1 Month Ago. -$0.12. 3 Months Ago. -$0.14. AbCellera Biologics Inc. analyst estimates, including ABCL earnings per share estimates and analyst recommendations. 4 ago 2023 ... As of Friday, August 04, AbCellera Biologics Inc's ABCL share price has dipped by 13.34%, which has investors questioning if this is right ...AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.19 per share a year ago. These ...Instagram:https://instagram. which bank gives debit card immediatelyhow to start trading forexarrived investment reviewswan etf ABCELLERA BIOLOGICS share price in real-time (A2QKXS / CA00288U1066), charts and analyses, news, key data, turnovers, company data. mutual fund brokeragebest etf platform Dec 1, 2023 · https://www.abcellera.com. AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. Inflation hits lowest level since 2021, Fed's preferred gauge shows. Find the latest AbCellera Biologics Inc. (ABCL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight ... masterworks io review Find the latest Institutional Holdings data for AbCellera Biologics Inc. Common Shares (ABCL) at Nasdaq.com.NASDAQ Health Care/Life Sciences Compare to Open 4.41 Prior Close 4.34 (11/21/23) 1 Day ABCL 2.07% DJIA 0.53% S&P Mid Cap 400 0.58% Health Care/Life Sciences 0.45% Overview Per-Share Earnings,...